- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 52.12M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 53.07M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 46.18M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $4K |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $40K |
| Capex | Q1 2026 · Mar 31, 2025 | $5K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $25.98M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$32.75M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $49.87M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $49.86M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $133.03M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $70.11M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $495.8M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $450.12M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $232.26M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $245.11M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $58.05M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $61.36M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $112.59M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $113.72M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $326.38M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $355.81M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $608.39M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $563.83M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.59 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.95 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.60 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.95 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $50.37M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $29.26M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $11.27M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $13.52M |
| Net Income | Q1 2026 · Mar 31, 2026 | $31.38M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$43.77M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $31.28M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$45.74M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.2M |